Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-017325
Filing Date
2025-06-13
Accepted
2025-06-13 19:38:23
Documents
1
Period of Report
2025-06-12

Document Format Files

Seq Description Document Type Size
1 form4-06132025_110620.html 4  
1 form4-06132025_110620.xml 4 3384
  Complete submission text file 0001415889-25-017325.txt   4871
Mailing Address C/O ANAPTYSBIO, INC. 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121
Business Address
Piscitelli Dominic (Reporting) CIK: 0001695028 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39269 | Film No.: 251048128

Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Issuer) CIK: 0001796280 (see all company filings)

EIN.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)